MedPath

Sulfur hexafluoride

Generic Name
Sulfur hexafluoride
Brand Names
Lumason, Sonovue, SonoVue
Drug Type
Small Molecule
Chemical Formula
F6S
CAS Number
2551-62-4
Unique Ingredient Identifier
WS7LR3I1D6

Overview

Sulfur hexafluoride is an ultrasound contrast agent indicated for use •in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult patients with suboptimal echocardiograms •in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients

Background

Sulfur hexafluoride is an ultrasound contrast agent indicated for use •in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult patients with suboptimal echocardiograms •in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients

Indication

Echocardiography: Sulfur hexafluoride is indicated for use in adult patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricularendocardial border. Ultrasonography of the Liver: Sulfur hexafluoride is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions.

Associated Conditions

No associated conditions information available.

Clinical Trials

FDA Approved Products

Lumason
Manufacturer:BRACCO DIAGNOSTICS INC
Route:INTRAVESICAL, INTRAVENOUS
Strength:60.7 mg in 1 mg
Approved: 2021/07/26
NDC:0270-7097
LumaSon
Manufacturer:BRACCO DIAGNOSTICS INC
Route:INTRAVESICAL, INTRAVENOUS
Strength:60.7 mg in 1 mg
Approved: 2021/01/10
NDC:0270-7097

Singapore Approved Products

SONOVUE POWDER FOR DISPERSION FOR INJECTION 8 microlitres/ml
Manufacturer:BRACCO SUISSE SA, Vetter Pharma-Fetigung GmbH & Co.KG (Solvent manufacturer)
Form:INJECTION, POWDER, FOR SOLUTION
Strength:8 microlitres/ml
Online:Yes
Approved: 2003/07/18
Approval:SIN12349P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath